BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 15654688)

  • 1. Olfactory neuroblastoma: the 22-year experience at one comprehensive cancer center.
    Diaz EM; Johnigan RH; Pero C; El-Naggar AK; Roberts DB; Barker JL; DeMonte F
    Head Neck; 2005 Feb; 27(2):138-49. PubMed ID: 15654688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Esthesioneuroblastoma: the Northwestern University experience.
    Argiris A; Dutra J; Tseke P; Haines K
    Laryngoscope; 2003 Jan; 113(1):155-60. PubMed ID: 12514401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapy and prognosis of intracranial invasive olfactory neuroblastoma.
    Jiang GY; Li FC; Chen WK; Liu AM; Cai WQ
    Otolaryngol Head Neck Surg; 2011 Dec; 145(6):951-5. PubMed ID: 21825099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome and prognostic factors in olfactory neuroblastoma: a rare cancer network study.
    Ozsahin M; Gruber G; Olszyk O; Karakoyun-Celik O; Pehlivan B; Azria D; Roelandts M; Kaanders JH; Cengiz M; Krengli M; Matzinger O; Zouhair A
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):992-7. PubMed ID: 20231062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proton-beam therapy for olfactory neuroblastoma.
    Nishimura H; Ogino T; Kawashima M; Nihei K; Arahira S; Onozawa M; Katsuta S; Nishio T
    Int J Radiat Oncol Biol Phys; 2007 Jul; 68(3):758-62. PubMed ID: 17398027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined modality therapy of esthesioneuroblastoma.
    McLean JN; Nunley SR; Klass C; Moore C; Müller S; Johnstone PA
    Otolaryngol Head Neck Surg; 2007 Jun; 136(6):998-1002. PubMed ID: 17547995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Long-term experiences in the therapy of esthesioneuroblastoma].
    Koch M; Constantinidis J; Dimmler A; Strauss C; Iro H
    Laryngorhinootologie; 2006 Oct; 85(10):723-30. PubMed ID: 16673299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Olfactory neuroblastoma: the University of Erlangen-Nuremberg experience 1975-2000.
    Constantinidis J; Steinhart H; Koch M; Buchfelder M; Schaenzer A; Weidenbecher M; Iro H
    Otolaryngol Head Neck Surg; 2004 May; 130(5):567-74. PubMed ID: 15138422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Results of salvage therapy after failure of initial treatment for advanced olfactory neuroblastoma.
    Kim HJ; Cho HJ; Kim KS; Lee HS; Kim HJ; Jung E; Yoon JH
    J Craniomaxillofac Surg; 2008 Jan; 36(1):47-52. PubMed ID: 18312791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Esthesioneuroblastoma: The Princess Margaret Hospital experience.
    Bachar G; Goldstein DP; Shah M; Tandon A; Ringash J; Pond G; Gullane PJ; Perez-Ordonez B; Gilbert RW; Brown DH; Gentili F; O'Sullivan B; Irish JC
    Head Neck; 2008 Dec; 30(12):1607-14. PubMed ID: 18798301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment modalities and outcomes of olfactory neuroblastoma.
    Song CM; Won TB; Lee CH; Kim DY; Rhee CS
    Laryngoscope; 2012 Nov; 122(11):2389-95. PubMed ID: 23070733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Esthesioneuroblastoma: the University of Iowa experience 1978-1998.
    Simon JH; Zhen W; McCulloch TM; Hoffman HT; Paulino AC; Mayr NA; Buatti JM
    Laryngoscope; 2001 Mar; 111(3):488-93. PubMed ID: 11224781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical analysis of 34 cases of esthesioneuroblastoma].
    Liu WS; Tang PZ; Xu GZ
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 2004 Jun; 39(6):328-32. PubMed ID: 15469075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Olfactory neuroblastoma: 15 years of experience.
    Kondo N; Takahashi H; Nii Y; Nagao J
    Anticancer Res; 2012 May; 32(5):1697-703. PubMed ID: 22593448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical analysis of 20 adults esthesioneuroblastoma with combined therapy].
    Li JS; Xie FY; Peng M; Han F
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2009 Jan; 44(1):36-9. PubMed ID: 19484986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term results of 28 esthesioneuroblastomas managed over 35 years.
    de Gabory L; Abdulkhaleq HM; Darrouzet V; Bébéar JP; Stoll D
    Head Neck; 2011 Jan; 33(1):82-6. PubMed ID: 20848423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surgical treatment versus concurrent chemoradiotherapy as an initial treatment modality in advanced olfactory neuroblastoma.
    Kim HJ; Kim CH; Lee BJ; Chung YS; Kim JK; Choi YS; Yoon JH
    Auris Nasus Larynx; 2007 Dec; 34(4):493-8. PubMed ID: 17499464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Esthesioneuroblastoma: 25-year experience at a single institution.
    Zafereo ME; Fakhri S; Prayson R; Batra PS; Lee J; Lanza DC; Citardi MJ
    Otolaryngol Head Neck Surg; 2008 Apr; 138(4):452-8. PubMed ID: 18359353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Esthesioneuroblastoma treated with non-craniofacial resection surgery followed by combined chemotherapy and radiotherapy: An alternative approach in limited resources.
    Rastogi M; Bhatt M; Chufal K; Srivastava M; Pant M; Srivastava K; Mehrotra S
    Jpn J Clin Oncol; 2006 Oct; 36(10):613-9. PubMed ID: 16926225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multimodality therapy including radiotherapy and chemotherapy improves event-free survival in stage C esthesioneuroblastoma.
    Eich HT; Hero B; Staar S; Micke O; Seegenschmiedt H; Mattke A; Berthold F; Müller RP
    Strahlenther Onkol; 2003 Apr; 179(4):233-40. PubMed ID: 12707712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.